Wealth Enhancement Advisory Services LLC Has $7.74 Million Holdings in Molina Healthcare, Inc $MOH

Wealth Enhancement Advisory Services LLC increased its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 182.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,094 shares of the company’s stock after purchasing an additional 24,609 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Molina Healthcare were worth $7,743,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Invesco Ltd. boosted its stake in Molina Healthcare by 25.9% during the second quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock worth $477,109,000 after buying an additional 329,759 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 4.6% during the 2nd quarter. AQR Capital Management LLC now owns 925,672 shares of the company’s stock worth $273,096,000 after acquiring an additional 40,714 shares during the period. Norges Bank acquired a new stake in shares of Molina Healthcare during the 2nd quarter valued at about $212,113,000. Charles Schwab Investment Management Inc. increased its stake in Molina Healthcare by 0.8% in the second quarter. Charles Schwab Investment Management Inc. now owns 419,457 shares of the company’s stock valued at $124,956,000 after acquiring an additional 3,216 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in Molina Healthcare by 8.5% in the second quarter. Bank of New York Mellon Corp now owns 364,716 shares of the company’s stock valued at $108,649,000 after acquiring an additional 28,562 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 357 shares of the business’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the transaction, the director owned 11,352 shares of the company’s stock, valued at $1,623,563.04. The trade was a 3.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday. Morgan Stanley set a $158.00 target price on Molina Healthcare in a research report on Friday, October 24th. Barclays increased their price objective on Molina Healthcare from $144.00 to $164.00 and gave the stock an “underweight” rating in a research note on Monday, January 5th. The Goldman Sachs Group reduced their target price on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a research note on Friday, October 24th. Finally, UBS Group dropped their target price on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating for the company in a research report on Friday, October 24th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $193.47.

Molina Healthcare Stock Performance

MOH stock opened at $202.05 on Friday. The company has a 50 day moving average price of $166.11 and a 200 day moving average price of $172.89. Molina Healthcare, Inc has a fifty-two week low of $133.40 and a fifty-two week high of $359.97. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.68 and a quick ratio of 1.68. The stock has a market capitalization of $10.95 billion, a PE ratio of 12.51 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing the consensus estimate of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The firm had revenue of $11.48 billion during the quarter, compared to analyst estimates of $10.99 billion. During the same period last year, the business posted $6.01 earnings per share. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.